101 related articles for article (PubMed ID: 23492572)
1. Study of an elevated carbohydrate antigen 19-9 concentration in a large health check-up cohort in China.
Tong Y; Song Z; Zhu W
Clin Chem Lab Med; 2013 Jul; 51(7):1459-66. PubMed ID: 23492572
[TBL] [Abstract][Full Text] [Related]
2. The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA.
Maestranzi S; Przemioslo R; Mitchell H; Sherwood RA
Ann Clin Biochem; 1998 Jan; 35 ( Pt 1)():99-103. PubMed ID: 9463746
[TBL] [Abstract][Full Text] [Related]
3. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.
Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H;
Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum CA 19-9 at screening tests: underlying conditions and role of abdominopelvic CT.
Kim JY; Kim SH; Kim SY
Eur Radiol; 2014 Oct; 24(10):2435-48. PubMed ID: 25113646
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease.
Waanders E; van Keimpema L; Brouwer JT; van Oijen MG; Aerts R; Sweep FC; Nevens F; Drenth JP
Liver Int; 2009 Oct; 29(9):1389-95. PubMed ID: 19515221
[TBL] [Abstract][Full Text] [Related]
8. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CA19-9 in the follow-up of colorectal cancer patients with elevated preoperative serum CA19-9.
Yang SH; Jiang JK; Chang SC; Juang CJ; Lin JK
Hepatogastroenterology; 2013; 60(125):1021-7. PubMed ID: 23321120
[TBL] [Abstract][Full Text] [Related]
10. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
Ng WW; Tong KJ; Tam TN; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
[TBL] [Abstract][Full Text] [Related]
11. How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects?
Kim BJ; Lee KT; Moon TG; Kang P; Lee JK; Kim JJ; Rhee JC
Dig Liver Dis; 2009 May; 41(5):364-9. PubMed ID: 19162573
[TBL] [Abstract][Full Text] [Related]
12. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
14. CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy.
Narita Y; Taniguchi H; Komori A; Nitta S; Yamaguchi K; Kondo C; Nomura M; Kadowaki S; Takahari D; Ura T; Andoh M; Muro K
Cancer Chemother Pharmacol; 2014 Feb; 73(2):409-16. PubMed ID: 24322376
[TBL] [Abstract][Full Text] [Related]
15. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.
Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X
Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155
[TBL] [Abstract][Full Text] [Related]
17. Two cases of the same family with the unusual elevation of CA19-9 levels.
Uyanik M; Sertoglu E; Serdar MA; Aydin FN; Ozgurtas T; Kurt I
Acta Med Port; 2014; 27(5):657-60. PubMed ID: 25409225
[TBL] [Abstract][Full Text] [Related]
18. Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection.
Bloomston M; Bekaii-Saab TS; Kosuri K; Cowgill SM; Melvin WS; Ellison EC; Muscarella P
Pancreas; 2006 Oct; 33(3):246-9. PubMed ID: 17003645
[TBL] [Abstract][Full Text] [Related]
19. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.
Mann DV; Edwards R; Ho S; Lau WY; Glazer G
Eur J Surg Oncol; 2000 Aug; 26(5):474-9. PubMed ID: 11016469
[TBL] [Abstract][Full Text] [Related]
20. [A case of hydronephrosis with high level of serum Span-1 antigen and CA19-9].
Kondoh K; Noguchi S; Shuin T; Masuda M; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Jan; 42(1):51-3. PubMed ID: 8686585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]